Key facts
- This page summarizes Jan de Witte's Form 4 filing for INTEGRA LIFESCIENCES HOLDINGS CORP (IART).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Nov 2024, 16:33.
Jan de Witte - 01 Nov 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- IART
- Reported as of
- 01 Nov 2024
- Net transaction value
- -$82,171
- SEC form
- 4
- Accepted by SEC
- 04 Nov 2024, 16:33:14 UTC
- Prior SEC filing
- 22 May 2024
- Next SEC filing
- 14 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Schwartz; Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jan de Witte filed Form 4 for INTEGRA LIFESCIENCES HOLDINGS CORP (IART) on 04 Nov 2024.
Change
- Previous filing in this sequence was filed on 22 May 2024.
- Current net transaction value: -$82,171.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IART
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +9,814
- Change %
- +53%
- Price
- $0.000000
- Shares after
- 28,164
- Date
- 01 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
IART
transaction
Common Stock
Tax liability
- Transaction value
- $82,171
- Shares
- -4,262
- Change %
- -15%
- Price
- $19.28
- Shares after
- 23,902
- Date
- 01 Nov 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IART
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -9,814
- Change %
- -7.5%
- Price
- $0.000000
- Shares after
- 120,466
- Date
- 01 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,814
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The second installment vested on 11/1/2024.